Co-infection between HIV-1 and HCV is common today in certain populations. However, treatment of 25 co-infection is full of challenges with special consideration for potential hepatic safety and drug-drug shows that the mt-QSAR method is available to predict chemical-protein interaction for discovering 45 multitarget inhibitors and provide a unique perspective on HIV/HCV co-infection treatment.
69
based, such as pharmacophore modeling [10] , similarity searching [11, 12] and molecular docking [13, 14] . performance between mt-QSAR and computational chemogenomic methods, and the result showed that mt-
79
QSAR had a better performance than chemogenomic, which had a high risk of overfitting and a high false 80 positive rate in the external validation set [18] .
81
In this study, mt-QSAR method was applied to predict the chemical-protein interactions (CPIs) for 11 and test set validation was used to evaluate the performance of all models. Thirdly, to verify the application 87 of this strategy, the developed mt-QSAR models were employed to predict CPI for 27 approved HIV-1 drugs 88 and 10 approved HCV drugs well as 9 compounds known to be active on one or more targets of HIV-1 or 89 HCV. The predicted results shown 18 hits to be potential HIV/HCV co-infection multitarget inhibitors, which 90 were further confirmed by reported bioactivity resulting in that 7 compounds actually interacted with HIV-1 91 and HCV targets simultaneously with diverse binding affinities. Our study indicates that machine learning-5 92 based mt-QSAR approaches could be potentially applied in discovery of HIV/HCV co-inhibitors and 93 multitarget drug discovery.
94

Results
95
Experimental datasets analysis
96
In this study, a total of 11 targets related to HIV-1 and 4 targets related to HCV were obtained. The 97 number of known small molecule inhibitors that act on HIV-1 and HCV targets were 11,006 and 1, 431, 98 respectively. The number of active compounds for each target was shown in Fig 2. A total of 11 datasets were 99 generated for HIV-1 system, including 157 inhibitors and 471 decoys for CXCR4, 370 inhibitors and 1,110 100 decoys for CCR5, 293 inhibitors and 879 decoys for GP120, 21 inhibitors and 63 decoys for GP41, 3 HIV-1 and 4 targets related to HCV are spatial distributed into five and two categories, respectively. As 117 showed in Fig 3A, the HIV-1 target space (n = 11) consists of five subfamilies, including membrane receptor
118
(n = 2), enzyme (n = 5), transcription factor (n = 1), kinase (n = 1) and unclassified protein (n = 2). Similarly,
119
the HCV target space (n = 4) is divided into two subfamilies, including enzyme (n = 2) and unclassified protein
120
(n = 2) in Fig 3B. Thus, the two data sets for HIV-1 and HCV have diverse target coverage.
121
Performance evaluation and comparison of models
122
The construction of all classification models, in this study, was primarily based on two classifiers (NB   7   123 and SVM) and two types of fingerprints (MACCS and ECFP6). Afterwards, internal 5-fold cross-validation 124 and external test set validation was executed in turn.
125
The could improve performance on yield and reducing false positive rate.
160
Moreover, the performance of different algorithms (NB and SVM) was also evaluated. With the 161 fingerprint MACCS (Fig 5A) , performance of the SVM models are generally superior to that of NB models.
162
In particular, for the models of HIV-1, MCC value from SVM models ranges from 0.70 to 1 with an average average of 0.96, which is dissimilar to NB that ranges from 0.50 to 1 and an average value of 0.81.
170
As described above, two fingerprints have no significant difference and the SVM algorithm is slightly 171 better than the NB. However, it is theoretically difficult to determine which fingerprint or algorithm is better 172 because each algorithm or fingerprint has its own advantages and disadvantages. corresponding binding values are presented in Table 4 . Fig 6 shows 
214
Above all, a set of 9 compounds (Fig 8) 
228
The results in Table 5 show that 5 compounds (CHEMBL16326, CHEMBL18927, CHEMBL449221, (see Fig 9C) , and the side chain of Arg503 and His502 of HCV NS5B (see Fig 9D) . Therefore, proline 249 sulfonamides inhibitors can affect HIV-1 RT and HCV NS5B and influence enaymatic function.
250
CHEMBL37541 and CHEMBL3612421 were also predicted to be active against HIV-1 PR and HCV
251
NS5B. CHEMBL3612421 was known HIV-1 PR inhibitor and CHEMBL37541 was known HIV-1 PR and
252
HCV NS5B inhibitor by experimentally validated [46, 58, 59] . As for CHEMBL37541, the dihydropyrone 253 moiety makes direct hydrogen bonds interaction with Ile50 of HIV-1 PR (see Fig 9E) and Ser476 of HCV
254
NS5B (see Fig 9F) . The 4-ethylphenol and cyclopentane groups fit into hydrophobic pockets consisting of the 255 residues Leu23, Leu23', Val82, Val82', Ile84 and Ile84' of HIV-1 PR (see Fig 9E) , and the residues Met423,
256
Ile482, Val485, Ala486, Leu489, Leu497 and Trp528 of HCV NS5B (see Fig 9F) . New predicted CPI pair In summary, 19 CPI pairs were predicted to be positive, and of which 17 CPI pairs were experimentally 275 confirmed to be active. Therefore, prediction success rate of 89.5% (17/19) indicates the reliability of the mt-
276
QSAR models. It is worth mentioning that remaining 2 CPI pairs related to 2 compounds deserve further 277 investigation by experiments, and the predicted targets might be the new targets for the known inhibitors.
278
Moreover, one CPI pair shows false negative in the prediction result.
279
The prediction results demonstrate that machine learning models have high specific and low false 
Discussion
285
In the past, the "one gene, one drug, one disease" was the main paradigm of drug discovery. However,
286
with the introduction of the concept of polypharmacology, multitarget therapy using a single drug that 287 simultaneously inhibits two or more targets may provide a new perspective. Here, the mt-QSAR method was 288 applied to identify the compounds acting on multiple targets for HIV/HCV co-infection.
289
In this study, based on the mt-QSAR method, 44 binary classifiers of 11 targets related to HIV-1 and 16 290 binary classifiers of 4 targets related to HCV were established to predict the CPIs. Besides, the prediction 291 reliability of models was confirmed by 5-fold cross-validation and test set validation.
292
To illustrate the application of the models, two different cases were performed to systematically predict 293 the multiple bioactivities for 27 approved HIV-1 drugs and 10 approved HCV drugs (case 1) and 9 compounds 294 that were known to be active toward at least one target of HIV-1 and HCV (case 2). For case 1, 21 approved 295 drugs were predicted to be active against more than one biological target. And the predictions were confirmed 296 by reported bioactivity data, the success rate was 44.6% and the failure rate was 1.8%. For case 2, 9 active 297 compounds toward at least one target (HIV-1 PR, RT, IN and HCV NS5B) were predicted to be multitarget 298 inhibitors by mt-QSAR models with a success rate of 89.5%. In short, the prediction results of above two 299 cases indicate that mt-QSAR models have a significant performance on prediction of multitarget inhibitors 300 against HIV/HCV co-infection.
301
As mentioned above, mt-QSAR method achieved satisfactory prediction accuracy, and machine learning 302 models were applicable for potential targets identification in this study. However, similarity searching and 303 molecular docking will be better choices for those targets with a small number of active molecules, such as 304 GP41, PKC, CYP3A, NS4B and NS5A whose active molecules are less than 30. Besides, machine learning 305 models and similarity searching neglect the interaction between receptor and ligands compared with molecular 306 docking. Therefore, it is necessary to choose a reasonable single-method or combining of multi-methods
307
according to specific situation.
308
In summary, computational methods utilized in this study could effectively detect multitarget co- 
Molecular representation
334
Each compound in the above data sets was represented using two different types of binary fingerprint 
mt-QSAR models building
343
In this study, all classification models were built by combining two machine learning algorithms (naive
344
Bayesian and support vector machine) and two molecular fingerprints (MACCS and ECFP6). In short, four 19 345 classifiers (NB_MACCS, NB_ECFP6, SVM_MACCS and SVM_ECFP6) were generated for each target. which a hyperplane with the maximal margin is generated to describe non-linear classification boundary.
367
Importantly, the classification is achieved through a kernel function. There are four basic kernels: linear,
368
polynomial, radial basis function (RBF) and sigmoid [67] . In most cases, RBF is preferred [67] . In this study,
369
the RBF kernel function was also used. The penalty parameter C and kernel parameter γ, involved in SVM,
370
were optimized through 5-fold cross-validation. 
Performance evaluation of mt-QSAR models
372
All models were evaluated by the internal 5-fold cross-validation and external test set validation. In 5-
373
fold cross-validation, the training set was divided into 5 subsets equally. Four subsets were used to train the 374 model, and the remaining one was used as an internal validation set. 
